Wedbush raised the firm’s price target on SpringWorks Therapeutics (SWTX) to $81 from $77 and keeps an Outperform rating on the shares following the Food and Drug Administration’s approval for ...

Wedbush initiated coverage of MannKind (MNKD) with an Outperform rating and $11 price target Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing ...

Wedbush analysts believe Tesla (NASDAQ:TSLA) CEO Elon Musk's unsolicited $97.4 billion bid for OpenAI's controlling nonprofit is unlikely to succeed but is intended to slow down the company's ...

Wedbush analyst M. Bryson now forecasts that the semiconductor producer will post earnings of $0.92 per share for the quarter, down from their previous estimate of $1.05.

Wedbush Securities views recent results from Palantir Technologies (NASDAQ:PLTR) and Salesforce (NYSE:CRM) as proof that artificial intelligence is reshaping the software industry. "The AI ...

Wedbush said Palantir Technologies (NASDAQ:PLTR) and Salesforce (NYSE:CRM) remain the two best software plays on the AI Revolution for 2025. Analysts led by Daniel Ives said, "Palantir has been a ...

Uber Technologies, Inc. (NYSE:UBER – Free Report) – Wedbush raised their Q1 2025 earnings estimates for Uber Technologies in a report released on Wednesday, February 5th. Wedbush analyst S.

The unsolicited $97.4B bid by a group led by Elon Musk for the non-profit that controls OpenAI is not competitive, and likely aimed at slowing down the startup's capital raising process ...

Wedbush Securities views recent results from Palantir Technologies (NASDAQ:PLTR) and Salesforce (NYSE:CRM) as proof that artificial intelligence is reshaping the software industry. "The AI software ...

Discover the Top 20 best Fashion Logos that define style in the industry! From iconic to innovative, explore how these logos captivate audiences! In fashion, logos are more than just symbols; they are ...